{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:24:07Z","timestamp":1790281447219,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research (NIHR)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Dementia Research Unit at South London and Maudsley NHS Foundation Trust"},{"DOI":"10.13039\/501100000764","name":"King\u05f3s College London","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000764","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["psy-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.psychres.2014.12.005","type":"journal-article","created":{"date-parts":[[2014,12,15]],"date-time":"2014-12-15T18:16:56Z","timestamp":1418667416000},"page":"402-406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["A systematic review of treatments for Impulse Control Disorders and related behaviours in Parkinson\u05f3s disease"],"prefix":"10.1016","volume":"225","author":[{"given":"Puja","family":"Tanwani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce A.","family":"Fernie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana V.","family":"Nik\u010devi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcantonio M.","family":"Spada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2014.12.005_bib1","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR\u00ae","year":"1994"},{"key":"10.1016\/j.psychres.2014.12.005_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jns.2011.05.044","article-title":"Impulsive and compulsive behaviors in Parkinson\u05f3s disease: a one-year follow-up study","volume":"310","author":"\u00c1vila","year":"2011","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.psychres.2014.12.005_bib3","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.parkreldis.2007.11.008","article-title":"Topiramate in managing impulse control disorders in Parkinson\u05f3s disease","volume":"14","author":"Bermejo","year":"2008","journal-title":"Parkinsonism and Related Disorders"},{"key":"10.1016\/j.psychres.2014.12.005_bib4","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.parkreldis.2007.11.008","article-title":"Topiramate in managing impulse control disorders in Parkinson\u05f3s disease","volume":"14","author":"Bermejo","year":"2008","journal-title":"Parkinsonism and Related Disorders"},{"key":"10.1016\/j.psychres.2014.12.005_bib5","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/JCP.0b013e3182549c2a","article-title":"Finasteride attenuates pathological gambling in patients with Parkinson disease","volume":"32","author":"Bortolato","year":"2012","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.psychres.2014.12.005_bib6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/WNF.0b013e31824d529b","article-title":"Opioid antagonist naltrexone for the treatment of pathological gambling in Parkinson disease","volume":"35","author":"Bosco","year":"2012","journal-title":"Clinical Neuropharmacology"},{"key":"10.1016\/j.psychres.2014.12.005_bib7","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson\u05f3s disease: dopaminergic pathophysiology and treatment","volume":"8","author":"Chaudhuri","year":"2009","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.psychres.2014.12.005_bib8","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1001\/archneur.65.12.1604","article-title":"Functional abnormalities underlying pathological gambling in Parkinson disease","volume":"65","author":"Cilia","year":"2008","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.psychres.2014.12.005_bib9","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00702-012-0934-4","article-title":"Genetics of impulse control disorders in Parkinson\u05f3s disease","volume":"120","author":"Cormier","year":"2013","journal-title":"Journal of Neural Transmission"},{"key":"10.1016\/j.psychres.2014.12.005_bib10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s10880-012-9302-7","article-title":"Impulse control disorders in Parkinson\u05f3s disease: a psychosocial perspective","volume":"19","author":"Delaney","year":"2012","journal-title":"Journal of Clinical Psychology in Medical Settings"},{"key":"10.1016\/j.psychres.2014.12.005_bib11","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/658415","article-title":"Impulse control disorders following deep brain stimulation of the subthalamic nucleus in Parkinson\u05f3s disease: clinical aspects","author":"Demetriades","year":"2011","journal-title":"Parkinson\u05f3s Disease"},{"key":"10.1016\/j.psychres.2014.12.005_bib12","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.biopsych.2009.09.021","article-title":"Dopamine receptor D4 polymorphism predicts the effect of l-DOPA on gambling behavior","volume":"67","author":"Eisenegger","year":"2010","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.12.005_bib13","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1007\/s00415-010-5603-7","article-title":"Zonisamide in managing impulse control disorders in Parkinson\u05f3s disease","volume":"257","author":"Emilio Bermejo","year":"2010","journal-title":"Journal of Neurology"},{"key":"10.1016\/j.psychres.2014.12.005_bib14","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/mds.20045","article-title":"Punding in Parkinson\u05f3s disease: its relation to the dopamine dysregulation syndrome","volume":"19","author":"Evans","year":"2004","journal-title":"Movement Disorders"},{"key":"10.1016\/j.psychres.2014.12.005_bib15","article-title":"Gambling in Ontario: A Report From a General Population Survey on Gambling-Related Problems and Opinions (ARF Research Document Series 130).","author":"Ferris","year":"1996","journal-title":"Toronto, Canada: Addiction Research Foundation"},{"key":"10.1016\/j.psychres.2014.12.005_bib16","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0006-3223(94)90636-X","article-title":"Punding on levodopa","volume":"36","author":"Friedman","year":"1994","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.12.005_bib17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/jnnp.68.4.423","article-title":"Hedonistic homeostatic dysregulation in patients with Parkinson\u05f3s disease on dopamine replacement therapies","volume":"68","author":"Giovannoni","year":"2000","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"10.1016\/j.psychres.2014.12.005_bib18","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","article-title":"The Yale\u2013Brown obsessive compulsive scale: I. Development, use, and reliability","volume":"46","author":"Goodman","year":"1989","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.psychres.2014.12.005_bib19","doi-asserted-by":"crossref","unstructured":"Guy, W. (Ed.), 1976. Clinical global impression scale. The ECDEU Assessment Manual for Psychopharmacology-Revised. Volume DHEW Publ No ADM 76 338, 218\u2013222.","DOI":"10.1037\/e591322011-001"},{"key":"10.1016\/j.psychres.2014.12.005_bib20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1468-1331.2008.02509.x","article-title":"Subthalamic deep brain stimulation and impulse control in Parkinson\u05f3s disease","volume":"16","author":"Halbig","year":"2009","journal-title":"European Journal of Neurology"},{"key":"10.1016\/j.psychres.2014.12.005_bib21","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/13554794.2012.713490","article-title":"Clozapine as a potential treatment for refractory impulsive, compulsive, and punding behaviors in Parkinson\u05f3s disease","volume":"19","author":"Hardwick","year":"2013","journal-title":"Neurocase"},{"key":"10.1016\/j.psychres.2014.12.005_bib22","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.psychres.2007.11.008","article-title":"The Gambling Symptom Assessment Scale (G-SAS): a reliability and validity study","volume":"166","author":"Kim","year":"2009","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.psychres.2014.12.005_bib23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/mds.10625","article-title":"Disabling repetitive behaviors in Parkinson\u05f3s disease","volume":"19","author":"Kurlan","year":"2004","journal-title":"Movement Disorders"},{"key":"10.1016\/j.psychres.2014.12.005_bib24","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/ageing\/afr078","article-title":"Behavioural disorders, disability and quality of life in Parkinson\u05f3s disease","volume":"40","author":"Leroi","year":"2011","journal-title":"Age & Ageing"},{"key":"10.1016\/j.psychres.2014.12.005_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/00207454.2011.633722","article-title":"Addiction-like manifestations and Parkinson\u05f3s disease: a large single center 9-year experience","volume":"122","author":"Limotai","year":"2012","journal-title":"International Journal of Neuroscience"},{"key":"10.1016\/j.psychres.2014.12.005_bib26","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/1531-8257(200009)15:5<873::AID-MDS1017>3.0.CO;2-I","article-title":"Beneficial effects of amantadine on l\u2010dopa\u2010induced dyskinesias in Parkinson\u05f3s disease","volume":"15","author":"Luginger","year":"2000","journal-title":"Movement Disorders"},{"key":"10.1016\/j.psychres.2014.12.005_bib27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/mds.21770","article-title":"Long\u2010term follow\u2010up of impulse control disorders in Parkinson\u05f3s disease","volume":"23","author":"Mamikonyan","year":"2008","journal-title":"Movement Disorders"},{"key":"10.1016\/j.psychres.2014.12.005_bib28","first-page":"100","article-title":"Influence of impulse control disorders on the quality of life among cognitively-intact Parkinson\u05f3s disease patients living in the Tomsk region, Russia","volume":"3","author":"Nikitina","year":"2013","journal-title":"Journal of Parkinson\u05f3s Disease"},{"key":"10.1016\/j.psychres.2014.12.005_bib29","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1212\/WNL.0b013e3182840678","article-title":"Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers","volume":"80","author":"Okai","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.psychres.2014.12.005_bib30","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1","article-title":"Factor structure of the Barratt impulsiveness scale","volume":"51","author":"Patton","year":"1995","journal-title":"Journal of Clinical Psychology"},{"key":"10.1016\/j.psychres.2014.12.005_bib31","unstructured":"Phillips, B., Ball, C., Sackett, D., Badenoch, D., Straus, S., Haynes, B.. Oxford Centre for Evidence-based Medicine levels of evidence (March 2009). Centre for Evidence Based Medicine Web site."},{"key":"10.1016\/j.psychres.2014.12.005_bib32","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.expneurol.2008.07.021","article-title":"Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson\u05f3s disease: an in vivo 11C-raclopride PET study","volume":"214","author":"Politis","year":"2008","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.psychres.2014.12.005_bib33","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/jnnp-2012-302684","article-title":"Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic","volume":"84","author":"Pondal","year":"2013","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"10.1016\/j.psychres.2014.12.005_bib34","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1212\/01.wnl.0000238401.76928.45","article-title":"Clinical features associated with impulse control disorders in Parkinson disease","volume":"67","author":"Pontone","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.psychres.2014.12.005_bib35","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/archneurol.2009.294","article-title":"Dopamine agonist withdrawal syndrome in Parkinson disease","volume":"67","author":"Rabinak","year":"2010","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.psychres.2014.12.005_bib36","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/mds.21667","article-title":"Quality of life in Parkinson\u05f3s disease: the relative importance of the symptoms","volume":"23","author":"Rahman","year":"2008","journal-title":"Movement Disorders"},{"key":"10.1016\/j.psychres.2014.12.005_bib37","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nn1378","article-title":"Pathological gambling is linked to reduced activation of the mesolimbic reward system","volume":"8","author":"Reuter","year":"2005","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.psychres.2014.12.005_bib38","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00415-012-6669-1","article-title":"Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson\u05f3s disease","volume":"260","author":"Sriram","year":"2013","journal-title":"Journal of Neurology"},{"key":"10.1016\/j.psychres.2014.12.005_bib39","first-page":"2","article-title":"Dopamine agonist therapy in early Parkinson\u05f3s disease","author":"Stowe","year":"2008","journal-title":"Cochrane Database Systematic Reviews"},{"key":"10.1016\/j.psychres.2014.12.005_bib40","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ana.22029","article-title":"Pathological gambling in Parkinson disease is reduced by amantadine","volume":"68","author":"Thomas","year":"2010","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.psychres.2014.12.005_bib41","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1212\/01.wnl.0000218206.20920.4d","article-title":"Prospective prevalence of pathologic gambling and medication association in Parkinson disease","volume":"66","author":"Voon","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.psychres.2014.12.005_bib42","doi-asserted-by":"crossref","first-page":"S196","DOI":"10.1016\/S0924-977X(09)70247-0","article-title":"Impulse control disorder: prevalence and possible risk factors","volume":"19","author":"Weintraub","year":"2009","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2014.12.005_bib43","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/mds.22571","article-title":"Validation of the questionnaire for impulsive\u2013compulsive disorders in Parkinson\u05f3s disease","volume":"24","author":"Weintraub","year":"2009","journal-title":"Movement Disorders"},{"key":"10.1016\/j.psychres.2014.12.005_bib44","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/mds.22571","article-title":"Validation of the questionnaire for impulsive\u2010compulsive disorders in Parkinson\u05f3s disease","volume":"24","author":"Weintraub","year":"2009","journal-title":"Movement Disorders"},{"key":"10.1016\/j.psychres.2014.12.005_bib45","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients","volume":"67","author":"Weintraub","year":"2010","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.psychres.2014.12.005_bib46","first-page":"S291","article-title":"Frequency of impulse control disorder symptoms in de novo Parkinson\u05f3s disease patients and healthy controls","volume":"27","author":"Weintraub","year":"2012","journal-title":"Movement Disorders"},{"key":"10.1016\/j.psychres.2014.12.005_bib47","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archneur.63.7.969","article-title":"Association of dopamine agonist use with impulse control disorders in Parkinson disease","volume":"63","author":"Weintraub","year":"2006","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.psychres.2014.12.005_bib48","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.22164","article-title":"Amantadine use associated with impulse control disorders in Parkinson disease in cross\u2010sectional study","volume":"68","author":"Weintraub","year":"2010","journal-title":"Annals of Neurology"},{"issue":"Suppl.3","key":"10.1016\/j.psychres.2014.12.005_bib49","first-page":"S196","article-title":"Randomized, double-blind, placebo-controlled study of naltrexone for impulse control disorders in Parkinson\u05f3s disease","volume":"19","author":"Weintraub","year":"2013","journal-title":"Movement Disorders"},{"key":"10.1016\/j.psychres.2014.12.005_bib50","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.amjopharm.2010.08.002","article-title":"Clinical review of treatment options for select nonmotor symptoms of Parkinson\u05f3s disease","volume":"8","author":"Wood","year":"2010","journal-title":"The American Journal of Geriatric Pharmacotherapy"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178114009883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178114009883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T13:09:03Z","timestamp":1566133743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178114009883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0165178114009883"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2014.12.005","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of treatments for Impulse Control Disorders and related behaviours in Parkinson\u05f3s disease","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2014.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}